The Zelio preferential issue proposes ₹167.95 crore of fresh capital at ₹853 per security, split almost evenly between equity shares for non-promoter investors and convertible warrants for promoters. The structure can fund growth, but it also stages dilution and leaves completion subject to a shareholder vote on 20 October 2026.

Zelio preferential issue: two instruments, one price

The BSE board-outcome filing records an issue price of ₹853 for both legs. Zelio E-Mobility proposes 9.73 lakh fully paid equity shares to four non-promoter allottees, raising up to ₹82.9969 crore, and 9.96 lakh warrants convertible into equity shares for promoter allottees, representing up to ₹84.9588 crore.

Added together, the two legs reach ₹167.9557 crore. Inc42 independently confirmed the board approval, the equity-and-warrant split and the scheduled shareholder review.

Zelio capital splitThe proposed 167.95 crore rupee raise is split between shares for non-promoters and warrants for promoters.Non-promoter shares₹83.00 crPromoter warrants₹84.96 crBoth legs use an issue price of ₹853 per security

Why the split matters

Direct equity creates issued shares once allotment conditions are satisfied. Warrants are different: they are convertible instruments that can become shares after prescribed payments and conversion conditions. That means the warrant leg can stage both cash receipt and dilution instead of delivering the full effect on the equity base at once.

The non-promoter equity leg brings outside institutional and private capital into the register. The filing names Motilal Oswal Financial Services, Calliope Capital Advisors, Param Value Investments and Hem Growth Opportunities Fund as proposed equity allottees. The promoter warrant leg signals additional sponsor participation, but investors should track the conversion timetable and payments rather than assuming every warrant is already a fully paid share.

This is the same analytical distinction highlighted in our OnEMI preferential issue analysis: headline fundraise value, cash timing and eventual dilution are related but not identical.

Board approval is not completion

The Zelio preferential issue remains a proposal until required approvals and allotment steps are completed. Shareholders are due to consider it at an extraordinary general meeting on 20 October 2026. The company must also comply with the pricing, disclosure and allotment requirements governing preferential issues.

Because the aggregate exceeds ₹100 crore, the board appointed Brickwork Ratings India as monitoring agency under the applicable SEBI framework, according to the filing. Monitoring does not eliminate execution risk, but it adds an external reporting layer around the stated use of proceeds.

Approval-to-capital pathBoard approval moves to shareholder vote, allotment and then deployment of growth capital.Board23 SepShareholders20 Oct voteCapitalafter allotment

What investors should measure

The first measure is completion: whether shareholders approve the resolutions and whether all named allottees subscribe on the disclosed terms. The second is cash timing, particularly for the warrants. The third is dilution, which depends on the pre-issue share count and the extent and timing of warrant conversion.

The fourth measure is deployment. A capital raise creates value only when the company turns it into productive assets, distribution, working capital or other uses that earn more than the cost of capital. Zelio’s subsequent filings should specify utilisation and allow investors to compare actual spending with the approved objects.

Our Venus Pipes preferential issue coverage explains why monitoring allotment, promoter participation and the post-issue capital structure is essential after a board announcement.

The governance angle

The same board meeting also approved seeking shareholder consent for related-party transactions, each up to ₹50 crore, with identified entities connected to directors or their relatives. Those proposals are separate from the securities issue, but their inclusion in the shareholder process makes the EGM an important governance checkpoint.

Investors should avoid combining the limits into an assumption that the company will necessarily transact the full amounts. Approval sets a ceiling and permission framework; actual transactions, if any, should be evaluated through later disclosures.

What the proposal means now

The Zelio preferential issue is a two-channel financing plan: outside investors receive direct equity, promoters receive convertible warrants, and both channels use the same ₹853 reference price. It is not yet cash in the bank, and the decisive next event is shareholder approval followed by allotment and monitored deployment.

That framing keeps the news precise. The board has defined the size, securities, price and proposed allottees. The market still needs evidence of approval, funding receipts, conversion progress and the operating returns generated from the capital.

Frequently asked questions

How much does the Zelio preferential issue target?

Zelio E-Mobility’s board approved equity shares and convertible warrants aggregating to about ₹167.95 crore, subject to shareholder approval.

How is the issue split?

About ₹83 crore comes from 9.73 lakh equity shares for non-promoter allottees, while about ₹84.96 crore comes from 9.96 lakh warrants for promoter allottees.

Is the money already raised?

Not yet. The board approved the proposal, but shareholders are scheduled to vote at an extraordinary general meeting on 20 October 2026.

Why are warrants different from shares?

Equity shares are issued directly, while warrants give holders a right to receive shares after conversion conditions and payments are met.

How to read the next disclosure

Readers should separate approvals, allotments and completed cash movements. An approval authorises a transaction; an allotment creates or transfers securities; a cash receipt changes funding; and later financial statements show whether management used that funding productively. Treating those stages as one event can overstate both certainty and economic impact.

It is also important to distinguish issuer proceeds from shareholder proceeds. Primary securities add capital to the company, while secondary sales pay an existing owner. Both can change the shareholder register and market liquidity, but only primary capital directly expands the issuer’s resources.

Finally, reported demand is not the same as risk-free funding. Investors still price credit, dilution, governance, liquidity and execution risk. The strongest follow-up evidence will come from exchange filings, shareholding patterns, audited statements and monitoring reports rather than promotional descriptions.

A disciplined follow-up should compare the announced terms with the next statutory record. For an ownership transfer, that means the shareholding pattern and any seller disclosure. For debt, it means listed-security records, interest schedules and the borrower’s financial statements. For a preferential issue, it means voting results, allotment notices, receipt of funds and warrant conversion updates. This sequence keeps analysis anchored to evidence and prevents an approved ceiling, bid book or negotiated transfer from being presented as revenue, profit or completed operating growth.

The Lapaas view

Everyone else is reporting the headline transaction; we are explaining the capital mechanism and the consequence. The useful question is not simply how large the announced number looks, but who supplied the money, who received it, what security or ownership changed, when the transaction becomes effective and which later disclosure can prove that the intended result occurred.

That approach prevents a funding headline from being mistaken for operating performance. It also gives founders, employees, creditors and minority shareholders a clearer way to judge the event after the announcement cycle ends.

Get the day’s top stories in your inbox

One concise email. No spam, unsubscribe anytime.